Autologous PRP Intra Ovarian Infusion to Restore Ovarian Function in Menopausal Women
Trial statusRecruiting
Trial phasePhase 2, Phase 3
Trial typeInterventional
Biological sexFemale
Age45-55
SponsorGenesis Athens Clinic
About this trial
Autologous PRP intra ovarian infusion may restore ovarian function, may promote folliculogenesis and may improve hormonal profile of women in menopause.
Eligibility criteria
Qualifiers
Age between 45-55 years old
Amenorrhea for at least 12 months
Discontinuation of any complementary/adjuvant treatment including hormone replacement, acupuncture, and botanotherapy, for at least three months prior to recruitment.
Willing to comply with study requirements
Disqualifiers
Any pathological disorder related to reproductive system anatomy
Previous POI diagnosis
Abnormal karyotype
Endometriosis
Trial design
Treatments tested in this trial
- Autologous PRP intra ovarian infusion
- Autologous PFP intra ovarian infusion
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Genesis Athens Clinic
Lead sponsor
National and Kapodistrian University of Athens
Collaborator
Source ClinicalTrials.gov